Craig-Hallum Initiates Eton Pharmaceutical(ETON.US) With Buy Rating
Eton Pharmaceuticals Closes Acquisition Of Increlex(R) (Mecasermin Injection) >ETON
Express News | Eton Pharmaceuticals Closes Acquisition of Increlex® (Mecasermin Injection)
Eton Pharmaceuticals Closes Acquisition of Increlex (Mecasermin Injection)
Eton Pharmaceuticals Announced The Full Readout From The Clinical Trial Evaluating PKU GOLIKE As A Protein Substitute For Phenylketonuria In Patients During Prolonged Fasting Periods
Express News | Eton Pharmaceuticals Announces Final Readout of Pku Golike® Clinical Trial
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE Clinical Trial
Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Top Owners Are Retail Investors With 58% Stake, While 26% Is Held by Institutions
Press Release: Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer
Eton Pharmaceuticals Analyst Ratings
H.C. Wainwright Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $15
Express News | Eton Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $15 From $11
Eton Pharmaceuticals Has Acquired The Us Rights To Amglidia (Glyburide Oral Suspension, Known As Glibenclamide In Europe) For Neonatal Diabetes Mellitus From AMMTeK, Potential US Marketing Application Submission Expected In 2026
Express News | Eton Pharmaceuticals Inc - Plans FDA Meeting in Q1 2025, Nda Submission in 2026
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
US Manufacturing Index Rises To 43, Highest Since 2020
After Leaping 29% Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Are Not Flying Under The Radar
Eton Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results. HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
H.C. Wainwright Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Maintains Target Price $11